Skip to main content

Table 1 Clinical characteristics of breast cancer tissues

From: Inconclusive role of human papillomavirus infection in breast cancer

Patient no.

Age

Tumor type

Tumor grade

No. of LN mets

% ER staining

% PR staining

1

49

ILC

III

18

1

0

2

55

IDC

II

1

NA

NA

4

43

DCIS

I

0

90

70

5

44

IDC,ILC

II

0

90

1

6

59

IDC

NA

3

90

60

7

63

IDC

II

0

90

70

8

42

DCIS

II

3

90

90

9

54

IDC

II

9

95

95

10

62

IDC

III

0

0

0

11

61

IDC

III

0

95

5

12

39

IDC

II

14

80

95

13

60

IDC

III

0

1

1

14

40

IDC

III

13

0

3

15

57

IDC

II

0

90

75

16

58

IDC

II

1

95

80

17

54

IDC

II

0

NA

NA

18

39

IDC

II

0

90

60

19

37

IDC

II

5

90

80

20

36

IDC

III

0

40

80

21

49

IDC

III

5

80

40

22

44

IDC

III

0

NA

NA

23

39

IDC

III

4

30

50

24

52

IDC

III

0

20

80

25

46

IDC

II

0

0

80

26

48

IDC

II

0

90

0

27

37

IDC

III

28

0

1

28

48

IDC

II

10

NA

NA

29

46

IDC

II

0

0

0

30

38

IDC

III

0

0

50

31

51

DCIS

D2

0

0

80

32

52

IDC

III

0

80

20

33

35

DCIS

D3

0

90

70

34

38

DCIS

D3

4

0

50

35

45

IDC

III

0

0

1

36

64

IDC

III

NA

NA

NA

37

57

IDC

II

1

90

90

38

45

IDC

II

5

95

95

39

50

IDC

III

5

85

90

40

43

IDC

II

0

  

41

47

DCIS

D3

0

NA

NA

42

52

DCIS

NA

0

85

70

43

49

IDC

III

4

  

44

48

ILC

II

10

-

-

45

50

IDC

II

NA

NA

NA

46

68

IDC,MBC

II

5

90

50

47

63

IDC,MBC

III

0

85

85

48

53

IDC

III

21

85

5

49

31

IDC

III

0

0

1

50

68

IDC

III

0

0

0

51

53

IDC

III

0

5

3

52

69

IDC

III

0

1

1

53

54

IDC

II

10

90

50

54

40

IDC

II

0

80

0

55

51

IDC

II

0

80

50

56

43

IDC

II

0

65

30

57

56

IDC

II

0

70

85

58

37

IDC

II

3

30

90

59

31

DCIS

III

15

95

30

60

48

ILC

II

0

40

60

61

74

DCIS

III

4

90

15

62

53

IDC

II

0

NA

NA

636

40

IDC

III

0

100

5

4

45

IDC

III

0

50

90

65

32

IDC

III

1

1

1

66

56

IDC

II

8

1

0

67

55

ILC

III

7

0

0

68

55

ILC

II

6

80

90

69

42

IDC

II

0

10

90

70

57

IDC

II

0

0

90

71

44

IDC

II

1

90

90

72

46

IDC

II

0

0

0

73

38

IDC

II

0

70

10

74

53

ILC

II

NA

NA

NA

75

47

IDC

II

0

50

10

76

61

IDC

III

3

0

30

77

42

IDC

II

0

40

70

  1. LN mets lymph node metastasis, % ER staining percentage of tumour cells stained for oestrogen receptor, % PR staining percentage of tumour cells stained for progesterone receptor, IDC invasive ductal carcinoma, ILC invasive lobular carcinoma, DCIS ductal carcinoma in situ, MBC mucinous breast adenocarcinoma, NA data not available